Insilico Medicine Announces an PROTAC R&D Collaboration with Arvinas
Insilico Medicine is proud to announce an R&D collaboration with Arvinas (NASDAQ: ARVN). This strategic partnership will involve Insilico Medicine’s AI-augmented platforms and close cooperation...
